Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Feith

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Molecular Cancer Therapeutics|October 17, 2014
Vorinostat downregulates CD30 and decreases brentuximab vedotin efficacy in human lymphocytesZainul S Hasanali, Elliot M Epner, David J Feith, et al.
Frontiers in Oncology|June 1, 2022
Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid ArthritisKatharine B Moosic, Kusuma Ananth, Felipe Andrade, et al.
International Journal of Molecular Sciences|September 28, 2024
The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism-An Unconventional Ally in Cancer TreatmentJohnson Ung, Miki Kassai, Su-Fern Tan, et al.
Molecular Carcinogenesis|January 16, 2007
Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion-sensitive and promotion-resistant genetic backgroundsDavid J Feith, Lisa M Shantz, Paula L Shoop, et al.
Carcinogenesis|May 22, 2012
S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotionChenxu Shi, Timothy K Cooper, Diane E McCloskey, et al.
Carcinogenesis|May 22, 2016
Carcinogen-specific mutations in preferred Ras-Raf pathway oncogenes directed by strand biasRoss R Keller, Shelley A Gestl, Amy Q Lu, et al.
NPJ Systems Biology and Applications|July 21, 2017
Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular phenotypesSteven Nathaniel Steinway, Jorge Gomez Tejeda Zañudo, Paul J Michel, et al.
Biochimica Et Biophysica Acta|August 14, 2013
Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cellsSamy A F Morad, Jonathan C Levin, Su-Fern Tan, et al.
Amino Acids|August 3, 2011
Characterization of transgenic mice with overexpression of spermidine synthaseChenxu Shi, Patricia A Welsh, Suzanne Sass-Kuhn, et al.
International Journal of Oncology|February 27, 2013
DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastomaDana-Lynn T Koomoa, Dirk Geerts, Ingo Lange, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Molecular Cancer Therapeutics|October 17, 2014
Vorinostat downregulates CD30 and decreases brentuximab vedotin efficacy in human lymphocytesZainul S Hasanali, Elliot M Epner, David J Feith, et al.
Frontiers in Oncology|June 1, 2022
Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid ArthritisKatharine B Moosic, Kusuma Ananth, Felipe Andrade, et al.
International Journal of Molecular Sciences|September 28, 2024
The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism-An Unconventional Ally in Cancer TreatmentJohnson Ung, Miki Kassai, Su-Fern Tan, et al.
Molecular Carcinogenesis|January 16, 2007
Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion-sensitive and promotion-resistant genetic backgroundsDavid J Feith, Lisa M Shantz, Paula L Shoop, et al.
Carcinogenesis|May 22, 2012
S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotionChenxu Shi, Timothy K Cooper, Diane E McCloskey, et al.
Carcinogenesis|May 22, 2016
Carcinogen-specific mutations in preferred Ras-Raf pathway oncogenes directed by strand biasRoss R Keller, Shelley A Gestl, Amy Q Lu, et al.
NPJ Systems Biology and Applications|July 21, 2017
Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular phenotypesSteven Nathaniel Steinway, Jorge Gomez Tejeda Zañudo, Paul J Michel, et al.
Biochimica Et Biophysica Acta|August 14, 2013
Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cellsSamy A F Morad, Jonathan C Levin, Su-Fern Tan, et al.
Amino Acids|August 3, 2011
Characterization of transgenic mice with overexpression of spermidine synthaseChenxu Shi, Patricia A Welsh, Suzanne Sass-Kuhn, et al.
International Journal of Oncology|February 27, 2013
DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastomaDana-Lynn T Koomoa, Dirk Geerts, Ingo Lange, et al.
Pageof 8